WHO ICTRP trial
Efficacy and Safety of the Lens Fragmentation Device in Cataract Patients…
ChiCTR2500102232 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500102232 |
|---|---|
| Public title | Efficacy and Safety of the Lens Fragmentation Device in Cataract Patients Undergoing Phacoemulsification: A Prospective, Multicenter, Randomized, Controlled Study |
| Scientific title | Efficacy and Safety of the Lens Fragmentation Device in Cataract Patients Undergoing Phacoemulsification: A Prospective, Multicenter, Randomized, Controlled Study |
| Primary sponsor | The Zhongshan Ophthalmic Center,Sun Yat-sen University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Cataract |
| Interventions | Control group:Phacoemulsification cataract surgery and intraocular lens implantation;Experimental group:Phacoemulsification cataract surgery and intraocular lens implantation using a lens fragmentation device |
| Registration date | May 12, 2025 |
| Target size | Control group:100;Experimental group:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: